ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $419,000 | +8.0% | 10,344 | -11.7% | 0.01% | -9.1% |
| Q3 2022 | $388,000 | -2.3% | 11,714 | +3.8% | 0.01% | +10.0% |
| Q2 2022 | $397,000 | -27.0% | 11,282 | -45.0% | 0.01% | +900.0% |
| Q2 2019 | $544,000 | +48.2% | 20,515 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $367,000 | +45.6% | 19,993 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $252,000 | -34.4% | 20,301 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $384,000 | +48.3% | 20,037 | +5.2% | 0.00% | 0.0% |
| Q2 2018 | $259,000 | +219.8% | 19,043 | +69.6% | 0.00% | – |
| Q1 2018 | $81,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |